Top

Reactions Weekly

Published in:

01-10-2023 | Rheumatoid Arthritis | Case report

Tofacitinib

Progressive fibrosis interstitial lung disease: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Mochizuki T, et al. Combination treatment with Janus kinase inhibitor and nintedanib for rheumatoid arthritis with progressive interstitial lung disease: A case report. Modern Rheumatology Case Reports 7: 350-353, No. 2, Jul 2023. Available from: URL: http://doi.org/10.1093/mrcr/rxad021

Title: Tofacitinib
Progressive fibrosis interstitial lung disease: case report
Publication date: 01-10-2023
Publisher: Springer International Publishing
Keywords: Rheumatoid Arthritis
Nintedanib
Pulmonary-Function Tests
Prednisolone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-48178-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tofacitinib

Progressive fibrosis interstitial lung disease: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Doxorubicin

Multiple drugs

Antithrombotics

Fluoxetine/lamotrigine/valproic-acid/valproic-acid interaction

Darbepoetin-alfa

Cotrimoxazole/digoxin interaction